ArticleFolia microbiologica2026
Diversity and antimicrobial potential of endophytic fungi from Egyptian desert medicinal plants.
Article in Folia microbiologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Fungal endophytes from desert medicinal plants represent a promising yet underexplored source of bioactive secondary metabolites. In this study, 33 ascomycetous endophytes were isolated from five desert medicinal plant species collected in Egypt: Thymelaea hirsuta (L.) Endl., Zygophyllum album L.f., Zygophyllum coccineum L., Asparagus horridus L., and Asphodelus ramosus L. Molecular analyses revealed several species with potential thermotolerance or plant-growth-promoting capabilities, suggesting that they may contribute to host resilience in harsh arid environments. Ethyl acetate extracts of 29 isolates were screened for their antimicrobial activities against Escherichia coli, Klebsiella pneumoniae, methicillin-resistant Staphylococcus aureus, and Candida albicans. Several strains exhibited notable inhibitory effects. In particular, Canariomyces notabilis (GenBank accession nos. PZ502997, PZ530688) and Taifanglania parvispora (GenBank accession nos. PZ503016, PZ530694) displayed pronounced antimicrobial activity. Taifanglania parvispora CCF 6980 exhibited the strongest activity against MRSA (28 mm inhibition zone), whereas Canariomyces notabilis CCF 6973 showed broad-spectrum antimicrobial activity, producing inhibition zones of 20-31 mm, with the highest activity observed against Candida albicans. These findings highlight their potential for further investigation, especially as their secondary metabolites remain uncharacterised. Overall, this study expands the known diversity of fungal endophytes associated with Egyptian desert medicinal plants and highlights several taxa as potential sources of novel antimicrobial compounds.
Indexed as
Identifiers
42525350What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.